Tzield (teplizumab)

pCPA File Number: 23489

Negotiation Status:

Under consideration for negotiation

Indication(s):

indicated to delay the onset of stage 3 type 1 diabetes (T1D) in adult and pediatric patients 8 years of age and older with stage 2 T1D

Sponsor/Manufacturer:

Sanofi-Aventis Canada Inc.

CDA-AMC Project Number:

SR0867-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable